SCHEMBL19863788

SCHEMBL19863788

CN(C)c1ccc(C(=O)c2cc(Cl)ccc2NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
POLB P06746 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 5/20 0.44
TP53 P04637 5/20 0.44
LMNA P02545 1/20 0.44
SERPINE1 P05121 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
THRB P10828 1/20 0.42
GAA P10253 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8258036 0.86 SLC10A6 (0.50) ALDH1A1POLBMAPTTP53LMNA
SCHEMBL19857833 0.83 MAPT (0.53) ALDH1A1POLBTDP1MAPTTP53
SCHEMBL19863786 0.82 CCR9 (0.54) ALDH1A1POLBMAPTTP53LMNA
SCHEMBL30478237 0.80 MAPT (0.43) ALDH1A1MAPTTP53LMNASERPINE1
SCHEMBL19857767 0.79 SMN1; SMN2 (0.53) ALDH1A1POLBTDP1MAPTTP53
SCHEMBL29259910 0.79 KDM4E (0.63) ALDH1A1SERPINE1MEN1KMT2AGAA
SCHEMBL16109601 0.78 RXFP1 (0.48) ALDH1A1POLBMAPTTP53LMNA
SCHEMBL24269577 0.77 ATR (0.53) ALDH1A1SERPINE1MEN1KMT2AGAA
SCHEMBL19857846 0.77 CCR9 (0.57) ALDH1A1POLBTDP1MAPTTP53
SCHEMBL6113108 0.76 MAPT (0.56) ALDH1A1TDP1MAPTTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 ALDH1A1 4269/4885POLB 1471/4885TDP1 1600/4885
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex EIF4E, EIF4A1, EIF4A2 ALDH1A1 4269/4885POLB 1471/4885TDP1 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.